SASP: How Senescent Cells Trigger System-Wide Inflammation

Expert Summary

The SASP is a complex secretory program involving hundreds of factors including inflammatory cytokines, chemokines, growth factors, proteases, and extracellular vesicles. SASP is driven primarily by NF-κB and C/EBPβ transcription factors activated by persistent DNA damage signaling. SASP can spread senescence to neighboring cells ("paracrine senescence"), drive cancer progression, and create a chronic inflammatory state that accelerates nearly every age-related disease.

Key Facts

• Core SASP components: IL-6 (inflammatory driver), IL-8/CXCL8 (neutrophil recruiter), MMP-3 and MMP-9 (matrix degraders), VEGF (angiogenesis promoter), PAI-1 (clot promoter), CXCL1/5 (immune cell recruiters), CCL2 (macrophage recruiter).
• Paracrine senescence: SASP factors (particularly IL-6, IL-1β, and exosomes containing active DNA damage signals) can induce neighboring healthy cells to become senescent. This "contagion of aging" allows a few senescent cells to create expanding senescent zones — explaining why senescence accelerates with age.
• Cancer promotion: MMP proteases degrade basement membranes, allowing cancer cell invasion. VEGF promotes tumor angiogenesis. IL-6 activates STAT3, promoting tumor survival. SASP creates a tumor-permissive microenvironment — particularly relevant in aged individuals.
• Metabolic effects: IL-6 and TNF-α from SASP induce insulin resistance in adipose and hepatic tissue. Senescent visceral fat cells may be the primary driver of metabolic syndrome in aging.
• SASP regulation: NF-κB and C/EBPβ are the master transcription factors. mTOR (specifically mTORC1 via 4EBP1) also promotes SASP translation. Rapamycin, quercetin, and metformin all suppress the mTOR-dependent component of SASP.
• Blood-based SASP markers: IL-6, MMP-3, MMP-9, and GDF15 are validated circulating SASP biomarkers that decrease measurably after senolytic treatment in clinical trials.

Recommended Products

Frequently Asked Questions

Is SASP always inflammatory?

SASP composition varies by cell type and senescence inducer. Wound healing SASP is temporarily beneficial (promoting tissue repair via PDGF-AA, VEGF). Age-related, chronic SASP is persistently harmful. The distinction is between transient, targeted SASP vs persistent, systemic SASP from accumulated senescent cells.

Can diet alone reduce SASP?

Anti-inflammatory diets (Mediterranean, high polyphenol) reduce SASP-related markers in clinical studies. However, dietary polyphenol concentrations (quercetin, fisetin, curcumin from food) are far below senolytic threshold — diet reduces SASP expression but cannot eliminate the senescent cells producing it.

Scientific References

• Coppé JP et al. Senescence-associated secretory phenotypes. PLOS Biology. 2008. PMID: 19053174
• Xu M et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018. PMID: 29988130